Success Rate of Single Versus Two Visit Regenerative Treatment Protocol in Non Vital Mature Anterior Teeth

October 23, 2018 updated by: lamiaa Mohamed Ragaei Lasheen, Cairo University

Evaluation of Success Rate of Non Vital Mature Anterior Teeth With Periapical Lesion Following Single Versus Two Visit Regenerative Treatment Protocol A Randomized Clinical Study

This study evaluates success rate of non vital mature anterior teeth with periapical lesion treated by regenerative endodontic protocol in single visit versus two visit technique.

Patients are randomized into two groups where treatment will be done either in one visit including access, disinfection, placing platelet rich plasma as scaffold and restoration or two visit protocol involving access, disinfection and placing calcium hydroxide as intracanal medicament in first visit followed by a second visit after 3 weeks involving reopening of the tooth, removing intracanal medicament and placing platelet rich plasma as scaffold then restoration. Success rate is defined as absence of subjective signs and symptoms along with healing of periapical lesion

Study Overview

Detailed Description

Title: Evaluation of Success Rate of Non Vital Mature Anterior Teeth with Periapical Lesion Following Single versus Two Visit Regenerative Treatment Protocol (A Randomized Clinical Trial) Regenerative endodontics can be defined as biologically based procedures designed to replace damaged structures, including dentin and root structures, as well as cells of the pulp-dentin complex.

The majority of endodontic patients are adults, thus the application of the tissue engineering concept to mature teeth could provide a biological treatment modality instead of the conventional one. In fact, several advantages were reported about regenerative procedures in well developed mature teeth. Reconstitution of the neurovascular system in root canals by pulp regeneration will provide pulp tissues with an immune system, which will function as the first line of defense against microbial challenge. Moreover, restoration of pulp dentine complex will protect the tooth during loading and mastication.

Different treatment protocols for pulp regeneration were reported in the literature regarding irrigation (type, concentration and time), intracanal medication, pulpal space barrier, incorporation and lack of scaffolds (blood clot, PRP,PRF, collagen) as well as recall visits.

Rationale for conducting the research and choice of comparators:

Multiple visits protocol has been the commonly used technique in regenerative endodontic procedures. It involves the placement of intracanal medicaments between visits (calcium hydroxide and triple antibiotic paste) which have many drawbacks such as difficulty in removal, tooth discoloration, weakening of the root and tooth loss.

Completing revascularization in one visit has many advantages. First, it reduces the chance of additional bacterial contamination of the space. Second, a single revascularization protocol may overcome the problem of poor patient compliance and reduce the number of appointments needed. Third, it can help to combat potential injury of the tooth and tooth discoloration Unfortunately, up till the moment it is not clear which protocol is the most effective. Thus randomized clinical trials are required to provide plausible answers to this question In the present research the recent single visit regenerative treatment for necrotic mature teeth will be compared to the conventionally used two visit one

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 35 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Single canal anterior tooth

    • Mature root
    • Non vital with radiographic evidence of periapical lesion
    • Periapical lesion of average size 2-5mm
    • Positive patient compliance for participation in the study.
    • Patients with good oral hygiene
    • Normal periodontal probing depth ≤ 3 mm

Exclusion Criteria:

  • Compromised remaining tooth structure that need post and core build up
  • Non restorable teeth
  • Vital teeth
  • Radiographic evidence of external or internal root resorption.
  • Roots showing fracture or ankylosis
  • Medically compromised patients
  • Pregnant women
  • Greater than grade I mobility or periodontal probing depth greater than 3mm
  • Immature tooth
  • Patients with pain, swelling or fistula tracts

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Single visit pulp regeneration
Regenerative endodontic procedure not involving placement of intracanal medicament will be done in single visit
Access cavity, disinfection, preparing and injecting platelet rich plasma, and restoring the tooth all done in one visit.
ACTIVE_COMPARATOR: Two visit pulp regeneration
Regenerative endodontic procedure involving placing intracanal medicament will be done in two visit
first visit : access, disinfection and placing calcium hydroxide as intracanal medicament second visit: re opening of tooth, preparing and injecting platelet rich plasma and restoring the tooth.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Post operative pain: NRS
Time Frame: 3, 6, 9 and 12 months
absence of pain reported by the patient by numerical rate scale, the 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")
3, 6, 9 and 12 months
Change in swelling and/or sinus
Time Frame: 3,6,9,12 months
The presence of swelling or sinus will be reported by a binary question yes/no
3,6,9,12 months
Periapical healing
Time Frame: 12 months
The existing periapical lesion will be measured by mm by CBCT before intiation of treatment and after one year
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Antimicrobial effect
Time Frame: before and after complete disinfection either in the same visit or after 3 weeks from the second visit
intracanal bacterial count by culture method
before and after complete disinfection either in the same visit or after 3 weeks from the second visit
Sensitivity
Time Frame: 3, 6, 9 and 12 months
Tooth giving respond to electrical pulp tester
3, 6, 9 and 12 months
Discoloration
Time Frame: 3, 6, 9 and 12 months
Recording tooth shade before and after treatment
3, 6, 9 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

January 1, 2019

Primary Completion (ANTICIPATED)

September 1, 2020

Study Completion (ANTICIPATED)

December 1, 2020

Study Registration Dates

First Submitted

October 14, 2018

First Submitted That Met QC Criteria

October 23, 2018

First Posted (ACTUAL)

October 24, 2018

Study Record Updates

Last Update Posted (ACTUAL)

October 24, 2018

Last Update Submitted That Met QC Criteria

October 23, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Teeth

Clinical Trials on Single visit pulp regeneration

3
Subscribe